Katja Issbrücker

p38 MAP Kinase—a molecular switch between VEGF‐induced angiogenesis and vascular hyperpermeability

N. Suttorp, A. Gaumann, G. Breier, 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

An Engineered Heparin-Binding Form of VEGF-E (hbVEGF-E). Biological effects in vitro and mobilizatiion of precursor cells

W. Schaper, C. Dehio, M. Clauss, 2004, Angiogenesis.

Analysis of Vascular Permeability in Vivo

M. Clauss, H. H. Marti, Katja Issbrücker, 2004 .

Dissection of monocyte and endothelial activities by using VEGF-receptor specific ligands.

W. Schaper, M. Clauss, M. Heil, 2003, Advances in experimental medicine and biology.

An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

S. Zahler, P. Boekstegers, C. Vogelmeier, 2003, The Journal of clinical investigation.

VEGFR-1–Selective VEGF Homologue PlGF Is Arteriogenic: Evidence for a Monocyte-Mediated Mechanism

P. Carmeliet, G. Golomb, W. Schaper, 2003, Circulation research.

NAB2, a Corepressor of EGR-1, Inhibits Vascular Endothelial Growth Factor-mediated Gene Induction and Angiogenic Responses of Endothelial Cells*

F. Gruber, B. Binder, G. Schabbauer, 2003, The Journal of Biological Chemistry.

An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

S. Zahler, P. Boekstegers, C. Vogelmeier, 2003, The Journal of clinical investigation.